Home > Healthcare > Medical Devices > Diagnostic Devices > Kidney Function Tests Market

Kidney Function Tests Market Size

Report ID: GMI3810
Published Date: May 2023
Report Format: PDF

Download Free Sample

Kidney Function Tests Market Size

Kidney Function Tests Market was valued at around USD 855 million in 2022 and is expected to boost the business growth at 6.2% CAGR over the forecast period.

To get key market trends

Download Free Sample

Major factors driving the market growth includes the rising prevalence of chronic kidney diseases, increased demand for highly precise kidney function test, technological advancements in rapid diagnostic tests, etc. The chronic kidney disease (CKD) is considered as one of the major public health concerns globally. The overall estimated prevalence of CKD is approximately 13.4% worldwide. CKD directly affects & contributes to the global disease burden in terms of morbidity and mortality worldwide.

Kidney Function Tests Market Report Attributes
Report Attribute	Details
Base Year:	2022
Kidney Function Tests Market Size in 2022:	USD 855 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	6.2%
2032 Value Projection:	USD 1.5 billion
Historical Data for:	2018 to 2022
No. of Pages:	210
Tables, Charts & Figures:	509
Segments covered:	Product Type, Test Type, End-use, and Region
Growth Drivers:	Rising prevalence of chronic kidney diseases and acute kidney injuries Surging awareness regarding availability of different diagnostic methods for kidney related disorders Increasing patient population for diabetes and hypertension Technological advancements coupled with rise in R&D investments for different kidney function tests
Pitfalls & Challenges:	Lack of awareness regarding kidney diseases

Learn more about the key segments shaping this market

Download Free Sample

As per the U.S. Renal Data System 2020 Annual Data Report statistics, the Medicare spending concerning with CKD External link beneficiaries aged 66 and above exceeded USD 70 billion in 2018, accounting for around 23.8% of Medicare spending in this age group. The rising contribution of such conditions that contribute to the overall disease burden is set to prove beneficial for the market. Thus, the rise in the prevalence of CKD conditions and increasing disease burden is set to fuel the kidney function tests market growth in the foreseeable future.

Kidney function tests are quick urine and blood tests that aid in locating and assessing any issues with the kidneys. One of the initial tests that can be performed to determine the health of the kidneys is urine testing, which is more prevalent. However, lack of awareness regarding kidney function tests may inhibit the marker revenue.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for kidney function tests was USD 855 million in 2022 and will witness 6.2% CAGR from 2023-2032 due to the growing technological advancements in rapid diagnostic tests.

Kidney function tests industry share from urine tests reached USD 529 million in 2022 owing to minimal risks of infection.

North America kidney function tests industry size will exceed USD 652 million by 2032 on account of the growing patient population for acute kidney injuries.

F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc., 77 Elektronika Kft, Quest Diagnostics and Nova Biomedical are some renowned kidney function test firms.